DGX
Quest Diagnostics, Inc.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$246.48
−0.39%Next report
Analyst consensus
- Next report date
- Oct 20, 2026
- EPS estimate
- $2.85
- Revenue estimate
- $3.0B
Latest reported
- Last report date
- Jul 23, 2026
- EPS actual
- $3.12
- EPS estimate
- $2.82
- Revenue actual
- $3.0B
- Revenue estimate
- $3.0B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 11
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +5.5%
- Revenue beats (12Q)
- 10
Analyst ratings
Sell-side consensus
- Consensus
- Hold
- Price target
- $252
- PT range
- $245 – $260
- Analysts
- 7
3 Buy4 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 23, 2026 | $2.82 | $3.12 | Beat 10.64% | $3.0B |
| Apr 21, 2026 | $2.37 | $2.50 | Beat 5.49% | $2.9B |
| Oct 21, 2025 | $2.50 | $2.60 | Beat 4.00% | $2.8B |
| Jul 22, 2025 | $2.57 | $2.62 | Beat 1.95% | $2.8B |
| Apr 22, 2025 | $2.15 | $2.21 | Beat 2.79% | $2.7B |
| Jan 30, 2025 | $2.19 | $2.23 | Beat 1.83% | $2.6B |
| Oct 22, 2024 | $2.26 | $2.30 | Beat 1.77% | $2.5B |
| Jul 23, 2024 | $2.34 | $2.35 | Beat 0.43% | $2.4B |
| Feb 1, 2024 | $2.11 | $2.15 | Beat 1.90% | $2.3B |
| Jul 26, 2023 | $2.25 | $2.30 | Beat 2.00% | $2.3B |
| Apr 27, 2023 | $1.98 | $2.04 | Beat 3.29% | $2.3B |
| Feb 2, 2023 | $1.91 | $1.98 | Beat 3.61% | $2.3B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 20, 2026